CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
22 hedge funds and large institutions have $996K invested in COSCIENS Biopharma Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
8
Closed
4
Calls
$43K
Puts
$54K
Net Calls
-$11K
Net Calls Change
+$1K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$487K |
| 2 |
2
Acadian Asset Management
Boston,
Massachusetts
|
$69K |
| 3 |
3
Millennium Management
New York
|
$21K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
SEI Investments
Oaks,
Pennsylvania
| $0 | 11 | +11 | New |
|
|
CF
27
Centaurus Financial
Anaheim,
California
| $0 | 17 | +17 | New |
|